Title | Type | SJR | H index | Total Docs. (2007) | Total Docs. (3years) | Total Refs. (2007) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2007) | %Female (2007) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Reviews of Physiology Biochemistry and Pharmacology | journal | 4.568 Q1 | 70 | 7 | 32 | 1963 | 222 | 32 | 5.78 | 280.43 | 27.78 | |
2 | Pharmacological Reviews | journal | 9.450 Q1 | 254 | 16 | 88 | 4334 | 1849 | 85 | 19.61 | 270.88 | 14.00 | |
3 | Pharmacology and Therapeutics | journal | 3.796 Q1 | 233 | 111 | 274 | 19051 | 2587 | 270 | 8.84 | 171.63 | 34.47 | |
4 | Medicinal Research Reviews | journal | 2.645 Q1 | 150 | 30 | 78 | 5067 | 643 | 78 | 7.66 | 168.90 | 31.82 | |
5 | Advances in Pharmacology | journal | 0.320 Q3 | 86 | 14 | 96 | 2270 | 63 | 89 | 0.74 | 162.14 | 28.57 | |
6 | Progress in Medicinal Chemistry | journal | 0.981 Q2 | 38 | 5 | 23 | 777 | 54 | 20 | 2.88 | 155.40 | 16.67 | |
7 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.517 Q1 | 82 | 13 | 36 | 1996 | 157 | 36 | 2.63 | 153.54 | 29.73 | |
8 | Annual Review of Pharmacology and Toxicology | journal | 11.263 Q1 | 224 | 24 | 69 | 3600 | 1674 | 69 | 24.02 | 150.00 | 17.46 | |
9 | Current Neuropharmacology | journal | 0.489 Q3 | 103 | 27 | 83 | 3824 | 86 | 79 | 0.94 | 141.63 | 21.15 | |
10 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.839 Q1 | 108 | 52 | 143 | 7350 | 751 | 137 | 5.98 | 141.35 | 28.57 | |
11 | Current Medicinal Chemistry | journal | 1.834 Q1 | 202 | 261 | 652 | 36052 | 3639 | 630 | 5.26 | 138.13 | 31.32 | |
12 | Drug Resistance Updates | journal | 2.935 Q1 | 132 | 17 | 78 | 2301 | 604 | 75 | 7.15 | 135.35 | 24.07 | |
13 | CNS and Neurological Disorders - Drug Targets | journal | 2.059 Q1 | 96 | 45 | 162 | 6068 | 794 | 147 | 4.47 | 134.84 | 28.72 | |
14 | Current Pharmaceutical Design | journal | 1.781 Q1 | 183 | 337 | 1056 | 38981 | 5047 | 939 | 4.98 | 115.67 | 30.67 | |
15 | Current Cancer Drug Targets | journal | 2.814 Q1 | 103 | 79 | 146 | 9022 | 840 | 143 | 5.77 | 114.20 | 30.65 | |
16 | Current Drug Targets | journal | 1.433 Q1 | 119 | 137 | 323 | 15626 | 1350 | 290 | 4.19 | 114.06 | 28.77 | |
17 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.211 Q3 | 27 | 35 | 141 | 3958 | 60 | 126 | 0.40 | 113.09 | 39.13 | |
18 | Infectious Disorders - Drug Targets | journal | 1.158 Q1 | 61 | 35 | 89 | 3848 | 270 | 83 | 2.97 | 109.94 | 29.17 | |
19 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.204 Q3 | 17 | 38 | 39 | 4108 | 8 | 34 | 0.21 | 108.11 | 39.39 | |
20 | Current Drug Metabolism | journal | 1.367 Q1 | 122 | 76 | 150 | 8173 | 850 | 144 | 4.97 | 107.54 | 36.40 | |
21 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.716 Q2 | 43 | 35 | 100 | 3696 | 233 | 100 | 2.16 | 105.60 | 35.71 | |
22 | Expert Opinion on Emerging Drugs | journal | 0.950 Q2 | 54 | 45 | 124 | 4719 | 377 | 124 | 3.05 | 104.87 | 27.59 | |
23 | Mini-Reviews in Medicinal Chemistry | journal | 1.113 Q1 | 107 | 114 | 339 | 11701 | 1183 | 322 | 3.32 | 102.64 | 28.78 | |
24 | Anti-Infective Agents | journal | 0.457 Q3 | 26 | 24 | 75 | 2422 | 83 | 69 | 0.92 | 100.92 | 18.18 | |
25 | Current Pharmacogenomics | journal | 0.218 Q3 | 12 | 27 | 89 | 2689 | 55 | 89 | 0.67 | 99.59 | 39.44 | |
26 | Expert Opinion on Therapeutic Targets | journal | 1.433 Q1 | 106 | 134 | 227 | 13332 | 756 | 212 | 3.39 | 99.49 | 32.14 | |
27 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.866 Q2 | 45 | 32 | 115 | 3098 | 306 | 108 | 2.62 | 96.81 | 35.11 | |
28 | Current Vascular Pharmacology | journal | 1.362 Q1 | 69 | 33 | 116 | 3168 | 482 | 111 | 4.51 | 96.00 | 16.67 | |
29 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.743 Q2 | 100 | 67 | 120 | 6384 | 333 | 118 | 2.78 | 95.28 | 29.75 | |
30 | Cellular and Molecular Life Sciences | journal | 3.265 Q1 | 261 | 275 | 804 | 25263 | 4711 | 800 | 5.76 | 91.87 | 33.61 | |
31 | Annual Report of Shionogi Research Laboratory | journal | 0.105 Q4 | 2 | 2 | 4 | 180 | 0 | 4 | 0.00 | 90.00 | 0.00 | |
32 | Food and Drug Law Journal | journal | 0.168 Q3 | 23 | 42 | 101 | 3769 | 35 | 99 | 0.35 | 89.74 | 38.57 | |
33 | Inflammation and Allergy - Drug Targets | journal | 1.235 Q1 | 55 | 30 | 32 | 2674 | 92 | 28 | 2.88 | 89.13 | 30.59 | |
34 | Expert Opinion on Biological Therapy | journal | 1.092 Q1 | 102 | 165 | 428 | 13835 | 1378 | 425 | 3.12 | 83.85 | 27.71 | |
35 | CNS Drug Reviews | journal | 1.292 Q1 | 64 | 26 | 69 | 2174 | 256 | 67 | 3.87 | 83.62 | 30.99 | |
36 | Reviews on Recent Clinical Trials | journal | 0.150 Q4 | 35 | 28 | 31 | 2317 | 7 | 30 | 0.23 | 82.75 | 28.57 | |
37 | Addiction Biology | journal | 1.142 Q1 | 93 | 36 | 114 | 2655 | 318 | 100 | 2.80 | 73.75 | 31.84 | |
38 | Expert Opinion on Pharmacotherapy | journal | 0.577 Q2 | 93 | 274 | 698 | 20007 | 1543 | 685 | 2.23 | 73.02 | 29.76 | |
39 | Core Evidence (discontinued) | journal | 0.110 Q4 | 29 | 10 | 20 | 726 | 3 | 19 | 0.15 | 72.60 | 46.67 | |
40 | Expert Review of Vaccines | journal | 0.801 Q2 | 105 | 97 | 263 | 6944 | 575 | 241 | 2.25 | 71.59 | 28.70 | |
41 | Expert Opinion on Investigational Drugs | journal | 1.190 Q1 | 117 | 170 | 411 | 12057 | 1514 | 390 | 3.87 | 70.92 | 24.87 | |
42 | Cardiovascular Drug Reviews | journal | 0.713 Q2 | 54 | 25 | 70 | 1751 | 183 | 69 | 2.29 | 70.04 | 13.43 | |
43 | BioDrugs | journal | 0.787 Q2 | 79 | 46 | 112 | 3178 | 323 | 110 | 2.87 | 69.09 | 22.73 | |
44 | Neurotherapeutics | journal | 2.567 Q1 | 136 | 80 | 162 | 5502 | 1103 | 146 | 6.15 | 68.78 | 31.07 | |
45 | Drugs of Today | journal | 0.541 Q3 | 57 | 72 | 247 | 4811 | 521 | 244 | 2.18 | 66.82 | 19.35 | |
46 | Chinese Medicine | journal | 0.145 Q4 | 56 | 13 | 4 | 867 | 2 | 3 | 0.50 | 66.69 | 20.90 | |
47 | Clinical Pharmacokinetics | journal | 1.429 Q1 | 184 | 68 | 241 | 4519 | 1307 | 232 | 4.92 | 66.46 | 29.65 | |
48 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 0.847 Q2 | 99 | 78 | 324 | 4878 | 891 | 315 | 2.35 | 62.54 | 36.46 | |
49 | Current Topics in Pharmacology | journal | 0.108 Q4 | 8 | 18 | 18 | 1118 | 2 | 18 | 0.11 | 62.11 | 38.30 | |
50 | Current Opinion in Molecular Therapeutics | journal | 0.985 Q2 | 67 | 72 | 238 | 4448 | 607 | 213 | 2.54 | 61.78 | 31.69 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®